Impact of fluorodeoxyglucose positron emission tomography on the clinical management of patients with glioma

Clinical Nuclear Medicine

Volumn 21, Issue 9, 1996, Pages 720-725

  Deshmukh, Asvin ^a,b   Scott, James A ^a,b   Palmer, Edwin L ^a,b   Hochberg, Fred H ^a,b   Gruber, Michael ^a,b   Fischman, Alan J ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GADOLINIUM;

ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; GLIOMA; HUMAN; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; RADIATION NECROSIS; TREATMENT PLANNING; TUMOR RECURRENCE;

BRAIN; BRAIN NEOPLASMS; DEOXYGLUCOSE; DIAGNOSIS, DIFFERENTIAL; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; GLIOMA; HUMANS; NEOPLASM RECURRENCE, LOCAL; RADIATION INJURIES; RETROSPECTIVE STUDIES; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0029811573     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-199609000-00010     Document Type: Article

References (35)

1. Mazziotta JC: Overview of PET and its Applications to Brain Imaging. In: Proceedings of the Forum on Investigational and Experimental Modalities: Clinical Applications of Positron Emission Tomography to Imaging of the Brain. Health Insurance Association of America, March 1991;5-7:5.
2. Krol G: Radiological Diagnosis of CNS Neoplasms. In: Neuro-Oncology IV: Recent Developments in the Management of Neuro-Oncological Illnesses. New York, Memorial Sloan-Kettering Cancer Center, 1991, pp 13-27.
3. Nazzaro JM, Neuwelt EA: Review article: The role of surgery in the management of supratentorial intermediate and high-grade astrocytomas in adults. J Neurosurg 73:331, 1990.
4. Salcman M: Surgical decision-making for malignant brain tumors. In Clinical Neurosurgery: Proceedings of the Congress of Neurological Surgeons. Baltimore, Williams and Wilkins. 1987, pp 285-313.
5. Nelson DF, Urtasun RC, Saunders WM, et al: Recent and current investigations of radiation therapy of malignant gliomas. Semin Oncol 13:46, 1986.
6. Shapiro WR, Shapiro JR: Principles of brain tumor chemotherapy. Semin Oncol 13:56, 1986.
7. Recht LD, Lew R, Smith TW: Suspected low-grade glioma: Is deferring treatment safe? Ann Neurol 31:431, 1992.
8. Shapiro WR: Low-grade gliomas: When to treat? Ann Neurol 31:447, 1992.
9. Mazziotta JC, Gilman S, Kelly PJ, et al: Scientific, clinical, and financial issues associated with PET imaging of the brain. In: Proceedings of the Forum on Investigational and Experimental Modalities: Clinical Applications of Positron Emission Tomography to Imaging of the Brain. Health Insurance Association of America, March 1991;5-7:3.
10. Coleman RE, Hoffman JM, Hanson MW, et al: Clinical application of PET for the evaluation of brain tumors. J Nucl Med 32:616, 1991.
11. Holman BL, Abdel-Dayem H: The clinical role of SPECT in patients with brain tumors. J Neuroimaging. 5(suppl 1):S34, 1995.
12. 18F] fluorodeoxyglucose and positron emission tomography. Neurology 32:1323, 1992.
13. Black KL, Emerick T, Hoh C, et al: Thallium-201 SPECT and positron emission tomography equal predictors of glioma grade and recurrence. Neurol Res 16:93, 1994.
14. Alavi JB, Alavi A, Chawluk J, et al: Positron emission tomography in patients with glioma: A predictor of prognosis. Cancer 62:1074, 1988.
15. Kosuda S, Fujii H, Aoki S, et al: Prediction of survival in patients with suspected recurrent cerebral tumors by quantitative thallium-201 single photon emission computed tomography. Int J Radiat Oncol Biol Phys 30:1201, 1994.
16. Gilman S: Overview of brain tumors. In: Proceedings of the Forum on Investigational and Experimental Modalities: Clinical Applications of Positron Emission Tomography to Imaging of the Brain. Health Insurance Association of America, March 1991;5-7:7.
17. Black K: PET utility in the neurosurgical evaluation and management of cerebral neoplasms. In Proceedings of the Forum on Investigational and Experimental Modalities: Clinical Applications of Positron Emission Tomography to Imaging of the Brain. Health Insurance Association of America. March 1991;5-7:16.
18. Tovi M, Lilja A, Bergstrom M, et al: Delineation of gliomas with magnetic resonance imaging using Gd-DTPA in comparison with computed tomography and positron emission tomography. Acta Radiologica 31:417, 1990.
19. Lilja A, Lundqvist H, Olsson Y, et al: Positron emission tomography and computed tomography in differential diagnosis between recurrent or residual glioma and treatment-induced brain lesions. Acta Radiologica 30:121, 1989.
20. Laohaprasit V, Silbergeld DL, Ojemann GA, et al: Postoperative CT contrast enhancement following lobectomy for epilepsy. J Neurosurg 73:392, 1990.
21. Ogawa T, Uemura K, Shishido F, et al: Changes of cerebral blood flow, and oxygen and glucose metabolism following radiochemotherapy of gliomas: A PET study. J Comput Assist Tomogr 12:290, 1988.
22. Mineura K, Suda Y, Yasuda T, et al: Early and late stage positron emission tomography (PET) studies on the hemocirculation and metabolism of seemingly normal brain tissue in patients with gliomas following radiochemotherapy. Acta Neurochir 93:110, 1988.
23. Ichiya Y, Kuwabara Y, Otsuka M, et al: Assessment of response to cancer therapy using fluorine-18-fluorodeoxyglucose and positron emission tomography. J Nucl Med 32:1655, 1991.
24. Burger PC, DuBois PJ, Schold SC, et al: Computerized tomographic and pathologic studies of the untreated, quiescent, and recurrent glioblastoma multiforme. J Neurosurg 58:159, 1983.
25. Martins AN, Johnston JH, Henry JM, et al: Delayed necrosis of the brain. J Neurosurg 47:336, 1977.
26. Dooms GC, Hecht S, Brant-Zawadski M, et al: Brain radiation lesions: MR imaging. Radiology 158:149, 1986.
27. Kendall BE, Jakubowski J, Pullicino P, Symon I: Difficulties in diagnosis of supratentorial gliomas by CAT scan. J Neurol Neurosurg Psych 42:485, 1979.
28. Di Chiro G, Brooks RA: PET-FDG of untreated and treated cerebral gliomas. J Nucl Med 29:421, 1988.
29. Di Chiro G, Oldfield E, Wright DC, et al: Cerebral necrosis after radiotherapy and/or intra-arterial chemotherapy for brain tumors: PET and neuropathologic studies. AJR 150:189, 1988.
30. 11 C-Methionine for diagnosis of recurrent brain tumor and radiation injury. Acta Radiologica 32:197, 1991.
31. 82Rb positron emission tomography. J Comput Assist Tomogr 563:121, 1987.
32. Carvalho PA, Schwartz RB, Alexander E, et al: Detection of recurrent gliomas with quantitative thallium-201/technetium-99m HMPAO single-photon emission computerized tomography. J Neurosurg 77:565, 1992.
33. 99mTc-HMPAO. AJNR Am J Neuroradiol 12:1187, 1991.
34. Strauss LG, Conti PS: The applications of PET in clinical oncology. J Nucl Med 32:623, 1991.
35. Francavilla TL, Miletich RS, Di Chiro G, et al: Positron emission tomography in the detection of malignant degeneration of low-grade gliomas. J Neurosurg 24:1, 1989.